Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Cash from Financing Activities

Amneal Pharmaceuticals Inc Cash from Financing Activities Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Cash from Financing Activities from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Cash from Financing Activities for the quarter ending December 12, 2018 was $-219m a 84.81% decrease of -186m year over year
  • Amneal Pharmaceuticals Inc Cash from Financing Activities for the last 12 months ending December 12, 2018 was $288m a 134.87% increase of 388m year over year
  • Amneal Pharmaceuticals Inc Annual Cash from Financing Activities for 2018 was $288m a 133.03% increase of 383m from 2017
  • Amneal Pharmaceuticals Inc Annual Cash from Financing Activities for 2017 was $-95m a 79.48% decrease of -76m from 2016
  • Amneal Pharmaceuticals Inc Annual Cash from Financing Activities for 2016 was $-19m a -28.17% increase of 5m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Cash from Financing Activities Data

12/2018$-219m
09/2018$83m
06/2018$457m
03/2018$-33m
12/2017$-2m
09/2017$-64m
06/2017$-4m
03/2017$-28m
12/2016$-9m

Annual AMRX Cash from Financing Activities Data

2018$288m
2017$-95m
2016$-19m
2015$-25m
2014$48m